Cannim’s Lumir flower product is the second medical cannabis product to gain access to the European medical marijuana industry. Both products are being managed through the Fast track access platform. This platform currently boasts of over 14 cultivars from all over the world since its launch in June. With Cantourage managing the flower’s value chain, cannim will be able to get into the European market in no time.
The creator of biohacking talks psychedelics, plant intelligence, integration, surrender, and why optimizing the human…
The violations had nothing to do with cannabis. Neither did nearly half the drone flights…
Beneficial yeast in cannabis cultivation is a legitimate scientific idea borrowed correctly from real agricultural…
Members of Outlawz have said for years that they mixed some of Tupac Shakur’s ashes…
State and local police made at least 218,152 marijuana-related arrests in 2025, including 200,960 for…
Three days in Philadelphia, September 25 to 27, with a free record-clearing clinic and a…